Tamoxifen
库存状态： In Stock
登录以查看价格
实时
已添加到 RFQ
仅供研究与分析用途。不可个人使用。
包装与处理
所示为供视觉参考的示意性产品包装。实际包装可能因包装规格、数量、储存条件和运输要求而异。
可提供文档
可应要求提供详细规格、证书和支持性文件。
可应要求提供详细规格、证书和支持性文件。
储存： 完整信息请参阅 MSDS。
危害： 准确信息请参阅 MSDS。
Tamoxifen 产品信息
Tamoxifen 归类于 API，用于分析研究、质量控制和药物对照品应用。 其关联物质为 Tamoxifen. 本产品由 Clearsynth 提供，目录号为 CS-T-43118.
Clearsynth 提供该化合物用于研究和分析用途，产品信息包括 CAS 号、分子式、分子量和产品咨询详情。
技术数据
描述
法规说明
Tamoxifen is supplied with detailed characterization data compliant with regulatory guideline. Tamoxifen can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Tamoxifen.
概述
"Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is dependent upon PAX2. Blocks estradiol-stimulated VEGF production in breast tumor cells."
同义词
Tamoxifen
应用说明
"Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is dependent upon PAX2. Blocks estradiol-stimulated VEGF production in breast tumor cells."
产品应用与法规搜索词
此参考标准的有用产品、供应商和法规搜索词。